RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Acceleron Pharma - Stock

Acceleron Pharma Dividend 2024

Acceleron Pharma Dividend

0 USD

Acceleron Pharma Dividend yield

Ticker

XLRN

ISIN

US00434H1086

WKN

A1W5LE

How much dividend does Acceleron Pharma 2024 pay?

According to the latest status from June 2024, Acceleron Pharma paid a total of 0 USD per share in dividends within the last 12 months. With the current Acceleron Pharma price of 178.75 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Acceleron Pharma Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Acceleron Pharma Dividend Safe?

Acceleron Pharma has been increasing the dividend for 0 years.

Over the past 10 years, Acceleron Pharma has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Acceleron Pharma's Dividend Distributions

Acceleron Pharma’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Acceleron Pharma's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Acceleron Pharma's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Acceleron Pharma’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Acceleron Pharma Aktienanalyse

What does Acceleron Pharma do?

Acceleron Pharma Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2003 by a group of scientists specializing in drug development in the fields of oncology and hematology. The company's business model is based on the discovery and development of innovative therapeutic solutions, particularly in the areas of oncology and rare diseases. They use a wide range of technologies to identify potential target molecules and test their effectiveness. Acceleron Pharma operates in three different business areas: oncology, hemoglobinopathies, and musculoskeletal diseases. In oncology, the company focuses on developing drugs to treat cancers such as multiple myeloma or pancreatic cancer. The hemoglobinopathies division of Acceleron Pharma develops therapies for patients with rare blood disorders such as beta-thalassemia and sickle cell disease. In the field of musculoskeletal diseases, the company is working on developing therapies for muscle, connective tissue, and joint disorders. One of Acceleron Pharma's key products is the drug Reblozyl, which was developed in collaboration with Bristol Myers Squibb. Reblozyl is the first FDA-approved medication for the treatment of anemia in patients with beta-thalassemia. The company has also entered into a partnership agreement with Celgene to develop medications for the treatment of inflammatory bowel diseases. Acceleron Pharma has also successfully partnered with other major pharmaceutical companies such as Pfizer and Sanofi in the past. Through these partnerships, the company has provided its technology platform for the discovery and development of drugs for various indications such as cancer and muscle diseases. Acceleron Pharma is a fast-growing company dedicated to researching and developing innovative therapies for rare diseases. With a wide range of technologies and a strong pipeline of clinical candidates, the company is well-equipped to treat patients affected by these rare diseases. Acceleron Pharma is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Acceleron Pharma stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about Acceleron Pharma Stock

How much dividend does Acceleron Pharma pay?

Over the past 12 months, Acceleron Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Acceleron Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Acceleron Pharma?

The current dividend yield of Acceleron Pharma is .

When does Acceleron Pharma pay dividends?

Acceleron Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Acceleron Pharma?

Acceleron Pharma paid dividends every year for the past 0 years.

What is the dividend of Acceleron Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Acceleron Pharma located?

Acceleron Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Acceleron Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Acceleron Pharma from 6/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Acceleron Pharma pay the last dividend?

The last dividend was paid out on 6/12/2024.

What was the dividend of Acceleron Pharma in the year 2023?

In the year 2023, Acceleron Pharma distributed 0 USD as dividends.

In which currency does Acceleron Pharma pay out the dividend?

The dividends of Acceleron Pharma are distributed in USD.

Andere Kennzahlen von Acceleron Pharma

Our stock analysis for Acceleron Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acceleron Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.